Table 1.

Clinical features, laboratory indicators, and initial treatment regimens in patients with Kimura disease and different diameters of tumors.

Characteristics	All (n = 33)	Tumor diameter <3 cm (n = 15)	Tumor diameter ≥3 cm (n = 18)	P value
Age (year)	391 ± 7	441 ± 8	351 ± 6	0.147
Gender (%)				0.790
Males	28 (84.8)	13 (86.7)	15 (83.3)
Females	5 (15.2)	2 (13.3)	3 (16.7)
BMI (kg/m2)	24.753 ± 0.64	24.293 ± 0.18	25.134 ± 0.03	0.513
Blood pressure
SBP (mmHg)	1261 ± 3	1301 ± 1	1231 ± 4	0.120
SDP (mmHg)	829 ±	851 ± 0	798 ±	0.069
Heart rate (bp/min)	789 ±	795 ±	771 ± 2	0.601
Tumor diameter (cm)	4.042 ± 0.50	2.050 ± 0.38	5.692 ± 0.29	<0.001
Lesion site (%)				0.427
Parotid gland	10 (30.3)	5 (33.3)	5 (27.8)
Neck	9 (27.3)	3 (20.0)	6 (33.3)
Submandibular space	7 (21.2)	3 (20.0)	4 (22.2)
Face	4 (12.1)	3 (20.0)	1 (5.6)
Limb	2 (6.0)	0 [0]	2 (11.1)
Lymphadenopathy	1 (3.0)	1 (6.7)	0 (0)
Lesion number (%)				0.805
Single	6 (18.2)	3 (20.0)	3 (16.7)
Multiple	27 (81.8)	12 (80.0)	15 (83.3)
Symptom (%)				0.095
Skin itch	9 (27.3%)	2 (13.3)	7 (38.9)
Fever	4 (12.1%)	1 (6.7)	3 (16.7)
Thirst	3 (15%)	1 (6.7)	2 (11.1)
Hoarseness	1 (6.7)	1 (6.7)	0 (0)
Blurred vision	2 (6%)	1 (6.7)	1 (5.6)
Laboratory indicators
Leukocyte (109/L)	8.252 ± 0.44	7.362 ± 0.05	8.992 ± 0.54	0.055
Eosinophil (109/L)	0.210 ± 0.19	0.140 ± 0.09	0.260 ± 0.23	0.061
Elective CRP (%)	2 (6.1%)	0 (0)	2 (11.1)	0.183
Elective ESR (%)	1 (3%)	1 (6.7)	0 (0)	0.266
Initial treatment regimens				0.417
Single surgery	18 (54.5%)	8 (53.3%)	10 (55.5%)
Single prednisone	7 (21.2%)	2 (13.3%)	5 (27.8%)
Combined therapy	8 (24.3%)	5 (33.3%)	3 (16.7%)

BMI, body mass index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; SBP, systolic blood pressure; SDP, systolic double products.